Opaleye Management Inc., 10% owner at Grace Therapeutics, bought GRCE on Sep 21, 2026
Data as of Oct 16
- Traded
- Sep 21, 2026
- Disclosed
- Sep 23, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
GRCE since disclosure
−10.8%
Similar stocks (XLV) since disclosure
+4.7%
XLV — its sector index fund
Change in closing price from Sep 23, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$11.2Kdisclosed Sep 23 · filed the same day